Reviewed by the HeyPsych Medical Review Board
Board-certified psychiatrists and mental health professionals
Frequency: If repeated, commonly every 12–16 weeks depending on return of muscle activity and patient goals
Duration: Single outpatient session per treatment cycle
Total Treatment Time: Ongoing cycles may be considered if benefits outweigh risks and standard depression care remains optimized
Glabellar muscle relaxation typically starts within 3–7 days; bruising or headache, if they occur, are usually short-lived.
Cosmetic effect is near peak; if mood improves, it is often noticed over the first few weeks rather than immediately.
Most studies include modest sample sizes, selective populations, and short follow-up. Optimal dosing, the best responder profile, and long-term psychiatric outcomes remain uncertain, and major depression guidelines do not recommend it as standard care.
title: Cost Considerations
insurance coverage: Cosmetic use is typically self-pay; use for depression is usually not covered because it is off-label and not guideline-standard
total treatment cost: If repeated, costs recur about every 3–4 months
typical session cost: $300–$800 per cycle (varies by product, dose, and region)
ux display: undefined
collapsible: undefined
heading: undefined
How it's different: Systemic treatment that targets neurotransmission and is supported by large evidence bases and guidelines; botulinum toxin is a localized injection with off-label psychiatric evidence.
When it might be better: Moderate to severe depression, recurrent depression, suicidality risk, or when guideline-based therapy has not been fully tried.
How it's different: Direct noninvasive brain stimulation with established protocols for treatment-resistant depression; botulinum toxin targets facial muscles and relies on indirect mechanisms.
When it might be better: Treatment-resistant depression where an evidence-based, guideline-endorsed intervention is desired and access is available.
How it's different: Skills-based treatment targeting thoughts, behaviors, and coping; botulinum toxin does not address cognitive patterns or life stressors directly.
When it might be better: Depression linked to stress, relationship patterns, anxiety comorbidity, or when long-term relapse prevention is a priority.
How it's different: Adds volume to soften static lines; botulinum toxin reduces muscle-driven movement lines and may alter facial feedback.
When it might be better: Primary concern is volume loss or static wrinkles rather than glabellar muscle overactivity.
No. It is approved for several medical and cosmetic indications, but depression use is off-label and investigational.
If it helps, people often notice changes over the first few weeks, commonly around 2–6 weeks rather than immediately.
When present, it often tracks the cosmetic duration, typically around 12–16 weeks, but individual patterns vary.
No. Evidence suggests some people respond and others do not, and it is not a substitute for standard treatments.
Usually yes. In research, it is commonly studied as an adjunct while other treatments remain stable.
It should not be used as a mood stabilizer. If bipolar disorder is suspected, mood stabilization comes first and this should be approached cautiously, if at all.
Most effects are local, but eyelid droop and unwanted asymmetry can occur. Rarely, toxin spread can cause generalized weakness and needs urgent evaluation.
Many people still look natural with conservative dosing, but some reduction in frowning is expected by design.
Typically no. Most people return to normal activities the same day, following aftercare instructions.
A practical trial is often one to two cycles with consistent technique and stable depression treatment, then reassess objectively.
It is not common, but any mood worsening should be taken seriously and discussed promptly with your clinician.
Not reliably. Cosmetic response confirms muscle weakening, but mood response likely depends on additional factors.
It can be, if presented clearly as off-label, the evidence is described accurately, safety screening is done, and standard depression care is not delayed.
This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.
This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.